Cargando…

UBTF facilitates melanoma progression via modulating MEK1/2-ERK1/2 signalling pathways by promoting GIT1 transcription

BACKGROUND: UBTF is an HMGB-box DNA binding protein and a necessary Pol I/Pol II basal transcription factor. It has been found that UBTF involves in carcinogenesis and progression of a few cancers. Nevertheless, the the biological function and potential molecular mechanism of UBTF in melanoma are st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jian, Zhang, Jiaojiao, Liu, Wenli, Ge, Rui, Gao, Tianyuan, Tian, Qiong, Mu, Xin, Zhao, Lingyu, Li, Xu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522148/ https://www.ncbi.nlm.nih.gov/pubmed/34663332 http://dx.doi.org/10.1186/s12935-021-02237-8

Ejemplares similares

Inhibiting CCN1 blocks AML cell growth by disrupting the MEK/ERK pathway
por: Niu, Chang-Chun, et al.
Publicado: (2014)

MeCP2, a target of miR-638, facilitates gastric cancer cell proliferation through activation of the MEK1/2–ERK1/2 signaling pathway by upregulating GIT1
por: Zhao, L Y, et al.
Publicado: (2017)

Circ_0032821 acts as an oncogene in cell proliferation, metastasis and autophagy in human gastric cancer cells in vitro and in vivo through activating MEK1/ERK1/2 signaling pathway
por: Jiang, Yuanyuan, et al.
Publicado: (2020)

MiR-155-5p suppresses SOX1 to promote proliferation of cholangiocarcinoma via RAF/MEK/ERK pathway
por: Wang, Da, et al.
Publicado: (2021)

Ribosomal DNA promoter recognition is determined in vivo by cooperation between UBTF1 and SL1 and is compromised in the UBTF-E210K neuroregression syndrome
por: Tremblay, Michel G., et al.
Publicado: (2022)

MKP-4 suppresses hepatocarcinogenesis by targeting ERK1/2 pathway
por: Shen, Zhongyi, et al.
Publicado: (2019)

Inhibition of the PI3K but not the MEK/ERK pathway sensitizes human glioma cells to alkylating drugs
por: Haas, Bodo, et al.
Publicado: (2018)

Down-regulation of TRIB3 inhibits the progression of ovarian cancer via MEK/ERK signaling pathway
por: Wang, Shuang, et al.
Publicado: (2020)

Dehydrocorydaline inhibits cell proliferation, migration and invasion via suppressing MEK1/2-ERK1/2 cascade in melanoma
por: Hu, Huanrong, et al.
Publicado: (2019)

Benzimidazoisoquinoline derivatives inhibit glioblastoma cell proliferation through down-regulating Raf/MEK/ERK and PI3K/AKT pathways
por: Zhang, Ya-Jun, et al.
Publicado: (2018)

GIT1 is a novel prognostic biomarker and facilitates tumor progression via activating ERK/MMP9 signaling in hepatocellular carcinoma
por: Chen, Junyi, et al.
Publicado: (2015)

Water-pipe smoking promotes epithelial–mesenchymal transition and invasion of human breast cancer cells via ERK1/ERK2 pathways
por: Sadek, Khaled W., et al.
Publicado: (2018)

Dehydrocorydaline Inhibits Cell Proliferation, Migration and Invasion via Suppressing MEK1/2-ERK1/2 Cascade in Melanoma [Corrigendum]
Publicado: (2021)

Macrophage GIT1 Contributes to Bone Regeneration by Regulating Inflammatory Responses in an ERK/NRF2‐Dependent Way
por: Zhao, Shu‐Jie, et al.
Publicado: (2020)

MEK inhibition induced downregulation of MRP1 and MRP3 expression in experimental hepatocellular carcinoma
por: Lin, Shibo, et al.
Publicado: (2013)

Epigallocatechin-3-gallate inhibits the growth and increases the apoptosis of human thyroid carcinoma cells through suppression of EGFR/RAS/RAF/MEK/ERK signaling pathway
por: Wu, Dongdong, et al.
Publicado: (2019)

Berberine reduces temozolomide resistance by inducing autophagy via the ERK1/2 signaling pathway in glioblastoma
por: Qu, Huiling, et al.
Publicado: (2020)

HNRNPA2B1 regulates the epithelial–mesenchymal transition in pancreatic cancer cells through the ERK/snail signalling pathway
por: Dai, Shengjie, et al.
Publicado: (2017)

Increased expression of YTHDF1 and HNRNPA2B1 as potent biomarkers for melanoma: a systematic analysis
por: Li, Tengda, et al.
Publicado: (2020)

LNK promotes the growth and metastasis of triple negative breast cancer via activating JAK/STAT3 and ERK1/2 pathway
por: Lv, Jianxin, et al.
Publicado: (2020)

Protein phosphatase 6 regulates trametinib sensitivity, a mitogen-activated protein kinase kinase (MEK) inhibitor, by regulating MEK1/2-ERK1/2 signaling in canine melanoma cells
por: YAMAMOTO, Miu, et al.
Publicado: (2023)

Blocking ERK1/2 signaling impairs TGF-β1 tumor promoting function but enhances its tumor suppressing role in intrahepatic cholangiocarcinoma cells
por: Sritananuwat, Phaijit, et al.
Publicado: (2017)

Extracellular cyclophilin-A stimulates ERK1/2 phosphorylation in a cell-dependent manner but broadly stimulates nuclear factor kappa B
por: Bahmed, Karim, et al.
Publicado: (2012)

The D Domain of LRRC4 anchors ERK1/2 in the cytoplasm and competitively inhibits MEK/ERK activation in glioma cells
por: Wang, Zeyou, et al.
Publicado: (2016)

Deregulation of Hepatic Mek1/2–Erk1/2 Signaling Module in Iron Overload Conditions
por: Tangudu, Naveen Kumar, et al.
Publicado: (2019)

Persistence of UBTF tandem duplications in remission in acute myeloid leukaemia
por: Harrop, Sean, et al.
Publicado: (2023)

The Effect of Arrestin Conformation on the Recruitment of c-Raf1, MEK1, and ERK1/2 Activation
por: Coffa, Sergio, et al.
Publicado: (2011)

MEK1/2 Inhibitor (GDC0623) Promotes Osteogenic Differentiation of Primary Osteoblasts Inhibited by IL-1β through the MEK-Erk1/2 and Jak/Stat3 Pathways
por: Zhang, Zeng-Qiao, et al.
Publicado: (2021)

Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signaling
por: Tripathi, Rakshamani, et al.
Publicado: (2020)

ZEB1-AS1 initiates a miRNA-mediated ceRNA network to facilitate gastric cancer progression
por: Ma, Ming-Hui, et al.
Publicado: (2019)

Cardiac Hormones Target the Ras-MEK 1/2-ERK 1/2 Kinase Cancer Signaling Pathways
por: Vesely, David L.
Publicado: (2011)

The MAPK MEK1/2-ERK1/2 Pathway and Its Implication in Hepatocyte Cell Cycle Control
por: Guégan, Jean-Philippe, et al.
Publicado: (2012)

Version control with Git and GitHub
por: Magana, Alex, et al.
Publicado: (2018)

Tetraspanin 7 promotes osteosarcoma cell invasion and metastasis by inducing EMT and activating the FAK-Src-Ras-ERK1/2 signaling pathway
por: Shao, Shijie, et al.
Publicado: (2022)

Synapse formation is regulated by the signaling adaptor GIT1
por: Zhang, Huaye, et al.
Publicado: (2003)

Head-and-neck squamous cell carcinoma risk in smokers: no association detected between phenotype and AHR, CYP1A1, CYP1A2, or CYP1B1 genotype
por: Jorge-Nebert, Lucia F., et al.
Publicado: (2016)

POU4F1 promotes the resistance of melanoma to BRAF inhibitors through MEK/ERK pathway activation and MITF up-regulation
por: Liu, Lin, et al.
Publicado: (2020)

Circular RNA circ-CSPP1 regulates CCNE2 to facilitate hepatocellular carcinoma cell growth via sponging miR-577
por: Sun, Qian, et al.
Publicado: (2020)

MEK inhibition induces apoptosis in osteosarcoma cells with constitutive ERK1/2 phosphorylation
por: Baranski, Zuzanna, et al.
Publicado: (2015)

KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth
por: Riverso, M, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vs4c5ahm2sr7l1dv7jv31mbkng